• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Brazil Pharmaceuticals and Healthcare Report Q4 2012 - Product Image

Brazil Pharmaceuticals and Healthcare Report Q4 2012

  • Published: October 2012
  • Region: Brazil
  • 104 Pages
  • Business Monitor International

FEATURED COMPANIES

  • Aché/Biosintética
  • Cristália
  • EMS Sigma
  • Eurofarma
  • GlaxoSmithKline
  • Medley
  • MORE

The Brazil Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Brazil's pharmaceuticals and healthcare industry.

BMI View:

The Brazilian pharmaceutical market is still our favourite regional market in Latin America despite the recent downgrade in our Risk/Reward Ratings. The government has increasingly invested in the healthcare sector and pharmaceutical industry to stimulate local production capacity, reduce the financial burden of diseases and lessen the country's trade deficit. Multinationals can capitalise on the strong growth of the market by introducing innovative, high-tech products and collaborating with local companies.

Headline Expenditure Projections

- Pharmaceuticals: BRL42.9bn (US$25.6bn) in 2011 to BRL47.7bn (US$23.9bn) in 2012;
+11.1% in local currency terms and -6.9% in US dollars terms. Forecast up from Q312 due to more optimistic industry projections.

- Healthcare: BRL345bn (US$206bn) in 2011 to BRL378bn (US$189bn) in 2012; +9.6% in local currency READ MORE >

Executive Summary 5

SWOT Analysis 7

Brazil Pharmaceuticals And Healthcare Industry SWOT 7

Brazil Political SWOT 8

Brazil Economic SWOT 8

Brazil Business Environment SWOT 9

Pharmaceutical Risk/Reward Ratings 10
Table: Americas Pharmaceutical Risk/Reward Ratings, Q312 10

Brazil – Market Summary 13

Regulatory Regime 14

Intellectual Property Environment 15

Counterfeits 17

Compulsory Licensing 18

Pricing Regime 19

Reimbursement Regime 20

OTC Regulations 21

Advertising 22

Industry Developments 24

Epidemiology 24

Healthcare Sector 26

Healthcare Sector Funding 27

Research And Development 27

Biotechnology 28

Clinical Trials 31

Medical Devices Market 31

Medical Device Industry – Recent Developments 33

Medical Device Distribution 33

Industry Forecast Scenario 34

Overall Market Forecast 34
Table: Pharmaceutical Sales Indicators 2008-2016 35

Key Growth Factors – Industry 36
Table: Healthcare Expenditure Indicators 2008-2016 37
Table: Healthcare Governmental Indicators 2008-2016 38
Table: Healthcare Private Indicators 2008-2016 38

Key Growth Factors – Macroeconomic 40

Prescription Drug Market Forecast 46
Table: Prescription Drug Sales Indicators 2008-2016 47

Patented Drug Market Forecast 48
Table: Patented Drug Market Indicators 2008-2016 49

Generic Drug Market Forecast 50
Table: Generic Drug Sales Indicators 2008-2016 53

OTC Medicine Market Forecast 54
Table: OTC Medicine Sales Indicators 2008-2016 55

Pharmaceutical Trade Forecast 56
Table: Exports and Imports Indicators 2008-2016 58

Medical Device Market Forecast 59

Brazil Pharmaceuticals & Healthcare Report Q4 2012

© Business Monitor International Ltd

Page 4
Table: Medical Devices Sales Indicators 2008-2016 60

Other Healthcare Data 61

Key Risks To our Forecast Scenario 61

Competitive Landscape 62

Pharmaceutical Industry 62

Top 20 Pharmaceutical Companies In Brazil By Sales In 2010 62

Innovative Drugmakers 63

Innovative Drugmakers – Recent Developments 63

Generic Drugmakers 64

OTC Sector 66

Pharmaceutical Distribution Sector 67

Pharmaceutical Retail Sector 68

Company Profiles 71

Aché/Biosintética 71

EMS Sigma 74

Eurofarma 76

Medley 78

Cristália 80

Sanofi 82

Pfizer 84

Merck & Co 86

Novartis 88

GlaxoSmithKline 90

Roche 92

Demographic Outlook 94
Table: Brazil's Population By Age Group, 1990-2020 ('000) 95
Table: Brazil's Population By Age Group, 1990-2020 (% of total) 96
Table: Brazil's Key Population Ratios, 1990-2020 97
Table: Brazil's Rural And Urban Population, 1990-2020 97

Glossary 98

BMI Methodology 100

How We Generate Our Pharmaceutical Industry Forecasts 100

Pharmaceuticals Business Environment Ratings 101

Risk/Reward Ratings Methodology 101

Ratings Overview 101
Table: Pharmaceutical Business Environment Indicators 102

Weighting 103
Table: Weighting Of Components 103

Sources 103

- Aché/Biosintética
- Cristália
- EMS Sigma
- Eurofarma
- GlaxoSmithKline
- Medley
- Merck & Co
- Novartis
- Pfizer
- Roche
- Sanofi

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos